A standard cholesterol result can be useful, but it is not the whole cardiovascular picture. The best biomarkers for heart health help show how many potentially harmful cholesterol-carrying particles are circulating, whether metabolic health may be adding to risk, and when a result deserves a more detailed clinical conversation.
For many adults, blood testing is a practical part of proactive health management, particularly where there is a family history of early heart disease, high cholesterol, diabetes, high blood pressure or a recent change in lifestyle. Results are most valuable when viewed together, alongside factors such as age, smoking status, blood pressure, weight, medical history and family history.
What can blood biomarkers tell you about heart health?
Heart and circulatory disease develops over time. Blood biomarkers do not diagnose every heart condition, and a normal result cannot guarantee that a person will never develop cardiovascular disease. What they can do is identify patterns associated with increased risk and support informed decisions about diet, activity, medicines and further assessment.
A useful cardiovascular blood test goes beyond a single total cholesterol figure. It considers the type and amount of cholesterol being carried in the bloodstream, how the body handles glucose, and whether there are other relevant risk markers.
The best biomarkers for heart health
LDL cholesterol
Low-density lipoprotein cholesterol, usually called LDL cholesterol, is often described as bad cholesterol. This is a simplification, but it reflects an important principle: LDL particles can enter artery walls and contribute to the development of atherosclerosis, the gradual narrowing and hardening of arteries.
LDL cholesterol remains a central marker in cardiovascular risk assessment. Lower levels are generally preferred for people at higher risk, although the most appropriate target depends on the individual. Someone with established cardiovascular disease, diabetes, chronic kidney disease or a strong family history may need a different clinical discussion from someone with no known risk factors.
Non-HDL cholesterol
Non-HDL cholesterol is calculated by subtracting HDL cholesterol from total cholesterol. It captures cholesterol carried by several particle types that can contribute to plaque formation, including LDL.
This measure can be particularly useful when triglycerides are raised or when a fasting sample is not practical. It provides a broad view of potentially atherogenic cholesterol and is commonly considered alongside LDL cholesterol rather than as a replacement for it.
Apolipoprotein B, or ApoB
ApoB is one of the most informative biomarkers for understanding cholesterol-related risk. Each potentially atherogenic particle, including LDL and remnant particles, contains one molecule of ApoB. Measuring ApoB therefore provides an estimate of the number of these particles in circulation.
This matters because two people can have a similar LDL cholesterol result but a different number of cholesterol-carrying particles. In some cases, especially where triglycerides are raised, insulin resistance is present or there is diabetes, ApoB can offer a clearer assessment of risk than LDL cholesterol alone.
ApoB is not required for every person, but it can be a valuable addition to a more detailed lipid profile. It is particularly worth discussing with a clinician if routine cholesterol results do not seem to match a person’s wider risk profile.
Lipoprotein(a), or Lp(a)
Lp(a) is a largely inherited cholesterol-related particle. A raised Lp(a) level can increase cardiovascular risk independently of standard cholesterol measures, and it is not usually lowered substantially by lifestyle changes.
Because levels are mainly determined by genetics, many people only need Lp(a) measured once in adulthood. Testing can be especially helpful where a close relative has had heart disease or a stroke at a younger age, where familial high cholesterol is suspected, or where cardiovascular disease has occurred despite otherwise unremarkable results.
A raised result is not a diagnosis and should not cause unnecessary alarm. It provides useful context for managing other modifiable risks, such as LDL cholesterol, blood pressure, smoking and diabetes.
Triglycerides
Triglycerides are a type of fat in the blood. They can rise after meals, alcohol intake, poorly controlled diabetes, excess body weight, certain medicines and some health conditions. Very high triglyceride levels require prompt medical assessment because they may also increase the risk of pancreatitis.
For heart health, mildly or moderately raised triglycerides are often considered alongside HDL cholesterol, non-HDL cholesterol and ApoB. An isolated result needs careful interpretation. Recent alcohol, a rich meal, acute illness or whether the sample was fasting can all affect the reading.
HDL cholesterol
High-density lipoprotein cholesterol is often known as good cholesterol. Higher HDL cholesterol has historically been associated with lower cardiovascular risk, but it should not be treated as a protective score that cancels out a raised LDL cholesterol or ApoB result.
HDL remains useful as part of a full lipid profile and overall risk calculation. However, the focus should be on the complete pattern of results, rather than trying to raise HDL cholesterol in isolation.
HbA1c and blood glucose
The relationship between blood sugar and cardiovascular health is significant. HbA1c measures average blood glucose levels over roughly the previous two to three months. It is used to help identify prediabetes and diabetes, both of which can increase the risk of cardiovascular disease over time.
Raised HbA1c does not always cause symptoms. Testing can therefore be valuable for people with a family history of diabetes, those carrying excess weight around the middle, people with polycystic ovary syndrome, or anyone previously advised that their glucose levels are borderline.
Fasting glucose may also be included in some assessments. It reflects blood sugar at one point in time, while HbA1c gives a longer-term view. Neither result should be interpreted in isolation if there are symptoms, pregnancy, anaemia, known blood disorders or other factors that may affect HbA1c accuracy.
High-sensitivity C-reactive protein, or hs-CRP
Hs-CRP measures low levels of C-reactive protein, a marker associated with inflammation. Higher levels can be linked with increased cardiovascular risk, but they are not specific to the heart. A cold, dental infection, injury, autoimmune condition or recent strenuous exercise can all raise CRP.
For this reason, hs-CRP is best used selectively and in context. It may add useful information where cardiovascular risk is uncertain, but it is not a stand-alone screening test. If hs-CRP is elevated, repeat testing when fully well may be appropriate before drawing conclusions.
Important markers that are not part of a blood test
A blood profile is only one part of cardiovascular assessment. Blood pressure is one of the most influential modifiable risk factors, yet it cannot be measured from a blood sample. Smoking, physical activity, sleep, diet, waist circumference, kidney health and family history also matter.
Symptoms should always take priority over screening results. Chest pressure, breathlessness, fainting, a racing or irregular heartbeat, or pain spreading to the arm, jaw, back or neck need timely medical assessment. Blood testing is not a substitute for urgent care, an ECG or cardiac imaging where these are clinically indicated.
Choosing the right heart health blood test
For a general check, a lipid profile that includes total cholesterol, LDL cholesterol, HDL cholesterol, non-HDL cholesterol and triglycerides provides a strong starting point. Adding HbA1c gives useful metabolic context.
A more detailed assessment may include ApoB and Lp(a), particularly for those with a family history of premature cardiovascular disease or results that warrant closer examination. Kidney function and liver function can also be relevant, especially for people taking certain medicines or managing long-term conditions.
The right panel depends on your reason for testing. A busy professional seeking a preventative check has different needs from someone monitoring known high cholesterol, while an individual with a strong inherited risk may benefit from more comprehensive testing and clinical review.
Preparing for your test and understanding the result
Many lipid tests can be performed without fasting, although fasting may be requested in certain circumstances, particularly if triglycerides are being assessed in detail. Follow the collection instructions supplied with your test. Avoid testing when acutely unwell if possible, as illness can temporarily affect some results.
Reliable analysis also depends on correct sample handling. MedTech Services Laboratory processes blood samples through a UKAS-accredited laboratory, with home collection options designed to make testing more accessible while maintaining appropriate laboratory standards.
When your results arrive, look for patterns rather than focusing on one flagged number. Consider whether you have previous results for comparison, whether the sample was fasting, and whether there have been recent changes in weight, activity, alcohol intake, medication or health. Doctor-reviewed results, where provided, can help identify when further discussion with your GP or another qualified healthcare professional is appropriate.
Heart health is rarely defined by one result. A well-chosen blood test gives you a clearer starting point, while the next step is using that information – calmly, consistently and with the right clinical support – to make decisions that fit your personal risk.